Santana, M.d.F.M.; Sawada, M.I.B.A.C.; Junior, D.R.S.; Giacaglia, M.B.; Reis, M.; Xavier, J.; Côrrea-Giannella, M.L.; Soriano, F.G.; Gebrim, L.H.; Ronsein, G.E.;
et al. Proteomic Profiling of HDL in Newly Diagnosed Breast Cancer Based on Tumor Molecular Classification and Clinical Stage of Disease. Cells 2024, 13, 1327.
https://doi.org/10.3390/cells13161327
AMA Style
Santana MdFM, Sawada MIBAC, Junior DRS, Giacaglia MB, Reis M, Xavier J, Côrrea-Giannella ML, Soriano FG, Gebrim LH, Ronsein GE,
et al. Proteomic Profiling of HDL in Newly Diagnosed Breast Cancer Based on Tumor Molecular Classification and Clinical Stage of Disease. Cells. 2024; 13(16):1327.
https://doi.org/10.3390/cells13161327
Chicago/Turabian Style
Santana, Monique de Fatima Mello, Maria Isabela Bloise Alves Caldas Sawada, Douglas Ricardo Souza Junior, Marcia Benacchio Giacaglia, Mozania Reis, Jacira Xavier, Maria Lucia Côrrea-Giannella, Francisco Garcia Soriano, Luiz Henrique Gebrim, Graziella Eliza Ronsein,
and et al. 2024. "Proteomic Profiling of HDL in Newly Diagnosed Breast Cancer Based on Tumor Molecular Classification and Clinical Stage of Disease" Cells 13, no. 16: 1327.
https://doi.org/10.3390/cells13161327
APA Style
Santana, M. d. F. M., Sawada, M. I. B. A. C., Junior, D. R. S., Giacaglia, M. B., Reis, M., Xavier, J., Côrrea-Giannella, M. L., Soriano, F. G., Gebrim, L. H., Ronsein, G. E., & Passarelli, M.
(2024). Proteomic Profiling of HDL in Newly Diagnosed Breast Cancer Based on Tumor Molecular Classification and Clinical Stage of Disease. Cells, 13(16), 1327.
https://doi.org/10.3390/cells13161327
